Back to Search
Start Over
Changes in BMD T-score from pre-to post-treatment with biosimilar teriparatide: A single-arm, multi-center study
- Source :
- Bone Reports; June 2023, Vol. 18 Issue: 1
- Publication Year :
- 2023
-
Abstract
- Teriparatide is a recombinant analog of the parathyroid hormone and an anabolic treatment modality for osteoporosis. This study aimed to evaluate the effectiveness of biosimilar teriparatide (CinnoPar®, CinnaGen Co., Iran) in osteoporotic patients after at least one year of treatment.
Details
- Language :
- English
- ISSN :
- 23521872
- Volume :
- 18
- Issue :
- 1
- Database :
- Supplemental Index
- Journal :
- Bone Reports
- Publication Type :
- Periodical
- Accession number :
- ejs63145969
- Full Text :
- https://doi.org/10.1016/j.bonr.2023.101689